Learn about ALIMTA to help patients with first‐line,
second‐line, and maintenance treatment of advanced or
metastatic nonsquamous non‐small cell lung cancer, as
well as MPM.
Find Cash Advance, Debt Consolidation and more at Non-Small-Cell-Lung-Cancer.org. Get the best of Insurance or Free Credit Report, browse our section on Cell Phones or learn about Life Insurance. Non-Small-Cell-Lung-Cancer.org is the site for Cash Advance
ABRAXANE (paclitaxel) indications & prescribing information including chemotherapy for metastatic breast cancer, for first-line treatment of advanced non-small cell lung cancer and for first-line treatment of metastatic adenocarcinoma of the pancreas
ABRAXANE (paclitaxel) indications & prescribing information including chemotherapy for metastatic breast cancer, for first-line treatment of advanced non-small cell lung cancer and for first-line treatment of metastatic adenocarcinoma of the pancreas
Learn about ALIMTA to help patients with first‐line,
second‐line, and maintenance treatment of advanced or
metastatic nonsquamous non‐small cell lung cancer, as
well as MPM.
Learn about ALIMTA to help patients with first‐line,
second‐line, and maintenance treatment of advanced or
metastatic nonsquamous non‐small cell lung cancer, as
well as MPM.
A resource for patients with advanced nonsquamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM) to learn about ALIMTA therapy.
Learn about ALIMTA to help patients with first‐line,
second‐line, and maintenance treatment of advanced or
metastatic nonsquamous non‐small cell lung cancer, as
well as MPM.
Learn about ALIMTA to help patients with first‐line,
second‐line, and maintenance treatment of advanced or
metastatic nonsquamous non‐small cell lung cancer, as
well as MPM.
A resource for patients with advanced nonsquamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM) to learn about ALIMTA therapy.
Learn about ALIMTA to help patients with first‐line,
second‐line, and maintenance treatment of advanced or
metastatic nonsquamous non‐small cell lung cancer, as
well as MPM.
ABRAXANE (paclitaxel) indications & prescribing information including chemotherapy for metastatic breast cancer, for first-line treatment of advanced non-small cell lung cancer and for first-line treatment of metastatic adenocarcinoma of the pancreas
ABRAXANE (paclitaxel) indications & prescribing information including chemotherapy for metastatic breast cancer, for first-line treatment of advanced non-small cell lung cancer and for first-line treatment of metastatic adenocarcinoma of the pancreas
Learn about ALIMTA to help patients with first‐line,
second‐line, and maintenance treatment of advanced or
metastatic nonsquamous non‐small cell lung cancer, as
well as MPM.
A resource for patients with advanced nonsquamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM) to learn about ALIMTA therapy.
A resource for patients with advanced nonsquamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM) to learn about ALIMTA therapy.
A resource for patients with advanced nonsquamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM) to learn about ALIMTA therapy.
Learn about the TIGER trial program for adults diagnosed with non-small cell lung cancer that is metastatic or unresectable and tested positive for EGFRm+.
Official site of IRESSA (gefitinib), indicated in Europe for the treatment of adults with locally advanced or metastatic NSCLC with activating mutations of EGFR-TK across all lines of therapy.